Meet up with NimaGen's founders at NextGen Omics 2024 in London. Ruud van der Steen (CEO) and Joop Theelen (CSO) are seeking collaboration partners in Medical Microbiology & Infectious Disease and Human Genetics (Rare Disease, Inherited Disorders, Cancer).
Discover new business opportunities and get updated with the latest NimaGen innovations. Learn more about advanced Reverse Complement PCR technology, accelerating your Next-Generation Sequencing applications.
From licensing technology to design and manufacture of NGS Library Prep reagents and workflows.